The aorta is the largest vessel in your body and carries the blood away from your heart to the rest of your organs. A thoracic aneurysm occurs if the arterial wall below your rib cage weakens and develops a bulge, meaning blood is flowing into the weakened area.
The TEVAR procedure involves the placement of a covered stent (a metal mesh tube with a layer of fabric) into the weakened area of the artery. This provides a route for the blood to flow without pooling in the bulge.
If you have an aneurysm, it should be monitored by your doctor. It is recommended that you undergo treatment for the aneurysm if it has a diameter of over 5.5 cm or if it has expanded by over 0.5 mm within a six-month period, to prevent the aneurysm from rupturing, causing death. If the aneurysm is causing symptoms such as high blood pressure, pain and abnormal bleeding, you may require treatment.
If the thoracic aneurysm was caused by trauma, such as if the patient was in an accident, TEVAR is a way to rapidly cover the injured area, controlling bleeding and preventing death.
Although surgical treatments for thoracic aortic aneurysms are available, surgery has a significantly higher risk of serious complications and death.
In most cases, the patient is given an epidural and a local anaesthetic for the procedure, although in some cases the patient is given a general anaesthetic.
We will make a small cut in an artery at the top of your legs and will insert a sheath (a short tube to maintain safe access to the vessels). Then we will insert guidewires and catheters (thin flexible tubes) and direct them to the affected area under fluoroscopy. A contrast medium (dye) will be injected into the thoracic aorta so that the area clearly shows up under imaging for maximum accuracy. To place the stent, the interventional radiologist will insert it over a guidewire and move it to the correct location, where it will expand to seal the aneurysm or cover any leaks in the wall of the vessel.
After the procedure, your vital signs will be monitored and you will stay in hospital for 2-3 days. You may experience bruising and pain, though this can be treated with standard painkillers. Moving around once you are able to do so is encouraged. You will need to have the stent regularly checked using CT to ensure that the stent is in good condition and to avoid long-term problems.
The rate of successfully placing the stent and covering the aneurysm or tear is 98-99%. There are lower rates of pain and serious complications than with surgery, but the main risks associated with TEVAR are the stent moving to another area of the body and blood collecting in the aneurysm again. This means that you will require regular monitoring, so that if any problems do occur, they can be resolved as soon as possible.
Minor complications include the risk of bruising and infection. There are some serious complications associated with the procedure but the rate of serious complications is estimated to be less than 15%, and the risk of death during the procedure is less than 1.5%, which is nearly three times lower than the risk of dying during open surgery (around 4.5%).
An abdominal aortic aneurysm is an enlargement of the aorta, which is the main artery in the abdomen. The aorta is a blood vessel that carries oxygenated blood from the heart to much of the body, including the brain, intestines and kidneys and legs.
The most common cause of an aneurysm is atherosclerosis, which is caused by fat deposits in the vessel wall from decades of high blood pressure, high cholesterol, and/or smoking. Atherosclerosis weakens the vessel wall and the wall begins to thin and balloon outward causing the aorta to increase in size. Aortic aneurysms are typically found in older patients and those with relatives with the same condition.
Two of the most common symptoms of AAA are a deep, constant pain in the abdomen and pulsating feeling near the navel. Abdominal aortic aneurysms (AAA) are also known as ‘the silent killer’ because once they grow and rupture, there is an 80-90% risk of immediate death.
Patient is given general anaesthesia for the procedure. A small cut at the top of each leg so that they can insert a short tube (known as a sheath) called as femoral arteriotomy, which allows the vessels in your groin to be accessed safely. Using fluoroscopy for guidance, the interventional radiologist will insert guidewires and catheters (thin flexible tubes). A contrast medium (dye) will be injected into the area being treated so the exact location of the aneurysm can be seen under imaging. The interventional radiologist will then use the guidewire to move a stent to the aneurysm.
When the stent is placed in the correct location, it will expand, sealing the aneurysm and restoring normal blood flow through the vessel.
After the procedure, vital signs will be monitored and you will stay in hospital for 2-3 days atleast. You may experience bruising and pain, though this can be treated with standard painkillers. Moving around once you are able to do so is encouraged. You will need to have the stent regularly checked using CT or ultrasound to ensure that it is in good condition and to avoid long-term problems.
EVAR is recommended as a preventative treatment to avoid aneurysm rupture and death. The majority of patients suffer no immediate major problems and rupture of the aneurysm is avoided in over 99% of patients. There are lower rates of pain and serious complications than with surgery, but the main limitations of EVAR are that the stent may move to another area of the body and that blood may start collecting in the aneurysm again. This means that you will require regular monitoring, so that if any problems do occur, they can be resolved as soon as possible.
Minor complications include the risk of bruising and infection. There are some serious complications associated with the procedure, including death, stroke, tissue death, limb loss and injury to the kidneys. The rate of serious complications is estimated to be less than 10%, and the risk of death during the procedure is less than 1.5%, which is nearly three times lower than the risk of dying during open surgery (around 4.5%). Some patients react to the iodine in the dye used for imaging, which can affect the kidneys.